Genalyte Valuation, Funding & Investors

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

TOPI Imaging Technology is a Taiwan-based medical device manufacturer producing optical coherence tomography systems for retinal diagnostics and swept-source optical biometers for intraocular lens calculations. The company's OCT devices image macular degeneration and glaucoma while biometers measure axial length pre-surgery. TOPI supplies systems to ophthalmology clinics in Asia and exports to Europe under ISO 13485 certification.

Character Biosciences is a San Francisco-headquartered therapeutics developer applying genomics, longitudinal imaging, and machine learning to uncover disease progression drivers. Collaborations with health systems build phenotyped cohorts for research into ophthalmology and neurodegeneration, yielding targeted drug candidates.

Beacon Therapeutics is a London-headquartered gene therapy company targeting inherited retinal diseases causing blindness. The firm advances GT005, an AAV-delivered therapy for wet AMD choroidal neovascularization, with Phase 2b trials ongoing in the United States and Europe following seed funding from Oxford Nanopore founders.

Vanqua Bio is a Cambridge, Massachusetts-headquartered biotech firm developing therapies for neurodegenerative diseases like Parkinson's and ALS using a platform that screens human genetics and patient-derived neurons targeting lysosomal storage disorders and innate immune activation pathways.

Reprieve Cardiovascular is a Minnetonka-headquartered medical device company developing fluid management systems for congestive heart failure. Its Reprieve technology enables precise ultrafiltration during dialysis to decongest acute decompensated patients. As a subsidiary of CardioRenal Systems, it advances clinical trials for cardiac care integration.

AIRNA is a biotechnology company, based in Cambridge, Massachusetts, and Tübingen, Germany, that develops RNA editing therapeutics through its proprietary RESTORE+ platform. The platform makes precise edits to RNA to introduce beneficial genetic variants or repair disease-causing mutations, producing re-administrable medicines with simplified manufacturing compared to gene therapies. Its lead candidate targets alpha-1 antitrypsin deficiency, a genetic disorder that causes lung and liver disease, with additional programs planned in cardiometabolic conditions.

Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

InSightec is a Haifa-based pioneer in magnetic resonance-guided focused ultrasound for non-invasive surgeries. The Exablate Neuro system treats essential tremor and Parkinsonian tremor, earning FDA approval in 2016 after initial uterine fibroid clearance in 2004. InSightec's technology also addresses bone metastases pain and adenomyosis, with installations in over 100 centers globally including Mayo Clinic and University of Toronto.

Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.